Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 651 - 700 out of 14,157

Document Document Title
WO/2017/104798A1
The objective of a first invention of the present invention is to provide a method that makes it possible to efficiently produce an oxidation reaction product of a hydrocarbon or derivative thereof using the hydrocarbon or derivative the...  
WO/2017/104589A1
Provided is a method for producing a perfluoroalkylated compound at low cost, safely and with high efficiency. A method for producing a perfluoroalkylated compound, comprising reacting a bis(perfluoroalkanoyl)peroxide with a compound tha...  
WO/2017/101553A1
Disclosed are a fluorene multifunctional photoinitiator as represented by general formula (I), a photosensitive resin composition containing same, and the preparation thereof and uses of the two. The compound has the advantages of simple...  
WO/2017/101791A1
Disclosed are a compound and a use thereof in preparing a drug, and in particular, provided in the present invention are: the compound as shown in formula (I) or a stereoisomer, a geometric isomer, a tautomer, a racemate, a nitroxide, a ...  
WO/2017/100985A1
Disclosed is a method for preparing 2,2-dihalo-1,3-dicarbonyl derivatives. The method is applicable in a broad range of 1,3-dicarbonyl derivatives, which have various types of readily available raw materials. The method is utilized to pr...  
WO/2017/098048A1
The present invention is directed to a process for the manufacture of 6,10, 14- trimethylpentadecan-2-one ("C18-ketone") comprising the step of hydrogenating a mixture of (5E,9E)-farnesylacetone and (5Z,9E)- farnesylacetone with hydrogen...  
WO/2017/098049A1
The present invention is directed to a process for the manufacture of 6,10,14- trimethylpentadecan-2-one ("C18-ketone") comprising the step of hydrogenating a mixture of (5E, 9E)-farnesylacetone and (5Z, 9E)- farnesylacetone with hydroge...  
WO/2017/099072A1
Provided is a method in which a hydroperoxide is decomposed quickly and with high selectivity using an alkaline aqueous solution and the alkali is recovered and recycled, thereby producing the corresponding target ketone and/or alcohol a...  
WO/2017/099210A1
The present invention addresses the problem of providing a novel nuclear factor κB (NF-κB) inhibitor. An NF-κB inhibitor that comprises, as an active ingredient, a naphthoquinone compound represented by general formula (1) or a pharma...  
WO/2017/097938A1
A compound of formula (I), in which, independently, R1 is selected from H and methyl; R2 is selected from H, and methyl; R3 is selected from H, methyl and ethyl; R4 is selected from H, methyl and ethyl; or R3 and R4 together form a ring ...  
WO/2016/144909A9
Provided herein are redox flow (e.g., rechargeable) batteries having a first aqueous electrolyte including a first type of redox active material (e.g., a quinone or alloxazine) and a second aqueous electrolyte including a second type of ...  
WO/2017/098050A1
The present invention is directed to a process for the manufacture of 6,10,14-trimethylpentadecan-2-one ("C18-ketone") comprising the step of hydrogenating a mixture of (3E,5E,9E)-3,4-dehydrofarnesylacetone and (3Z,5E,9E)-3,4-dehydrofarn...  
WO/2017/095237A1
The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to prot...  
WO/2017/093749A1
There is described a method of preparing a compound of formula I, and optical isomers thereof: in which R1 is hydrogen or a protecting group; said method comprising oxidising verbenone and optical isomers thereof.  
WO/2017/083967A1
The present invention provides purified compounds extracted from seaweeds having the formula (I): wherein R1 and R2 is each independently H or a fatty acid and their use for inhibiting the growth of cancer cells.  
WO/2017/087539A1
The use of long-chain alkenones to impart desired characteristics in personal care compositions for topical applications is described. The preparation of mixtures long-chain alkenones and synthetic derivatives thereof is presented. Examp...  
WO/2017/076264A1
The present invention relates to a class of compounds as shown in general formula I or pharmaceutically acceptable salts thereof, a preparation method therefor, application thereof as a small molecule tool that functions as a GPR84 agoni...  
WO/2017/072719A1
The present invention relates to a new process for the synthesis of 17β-hydroxy- des-A-androst-9,10-en-5-one, the compound of the following formula (1), which can be used as an intermediate in the synthesis of retroprogesterones.  
WO/2017/071871A1
The invention relates to the production of specific ketones of formulae (I) and (VI), as defined herein, which act as photolabile pro-fragrances.  
WO/2017/070651A1
Disclosed is a process for preparing (Z)-endoxifen, comprising (i) recrystallizing an input crystalline solid comprising a mixture of (Z)-endoxifen (1) and (E)-endoxifen (2) from a first solvent to provide a first crystalline solid and a...  
WO/2017/067634A1
The invention relates to the use of hydrophilic compounds of formula (I) as photopolymerization initiators of polymerizable substance mixtures, which contain unsaturated compounds, or to the photochemical cross-linking of linear polymers...  
WO/2017/065219A1
A phenacene compound represented by general formula (1). In general formula (1), R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 each independently represent a hydrogen atom or a group represented by general formula (2), and any one of R3, R...  
WO/2017/066668A1
Compositions are disclosed having a cytotoxic and/or vascular disrupting agent (VDA) payload attached to a linker. The linker can be a cathepsin B protease cleavable linker or a non-cleavable linker that may degrade intracellularly. Meth...  
WO/2017/066214A1
The present invention pertains to novel octahydro-indene compounds and their unexpected advantageous use thereof in enhancing, improving or modifying the fragrance of perfumes, colognes, toilet waters, fabric care products, personal prod...  
WO/2017/063327A1
The present invention provides a novel C-spiro-O-glycoside compound intermediate having a structural formula as shown in formula I. Also provided is a preparation method for the novel C-spiro-O-glycoside compound intermediate, comprising...  
WO/2017/060440A1
The present invention relates to a novel mixtures of cyclopentadecenone isomers, to the production and use thereof as a flavoring substance, in particular as an odoriferous substance, and to flavoring substance mixtures and products cont...  
WO/2017/060437A1
The present invention relates to a novel method for the purification of cyclohexadec-8-en-1-one, to a method for the production of cyclohexadec-8-en-1-one and cyclopentadecenones, to the substances and substance mixtures thereby produced...  
WO/2017/055964A1
A novel organometallic complex with high reliability is provided. The organometallic complex includes iridium and ligands coordinated to the iridium. The ligands are a dipivaloylmethanato ligand and a ligand including a phenyl group to w...  
WO/2017/057460A1
Provided is a method for producing an organic compound, wherein the organic compound is an industrially useful compound, and a deodorization step, for removing from a reaction solution odorants that are generated in or remaining after a ...  
WO/2017/058373A1
A hydrocarbon conversion process is described. The process includes contacting in a reactor an inert gas with one or more catalyst compositions suitable for methylation of toluene and hydrogenation of phenol; contacting a reducing agent ...  
WO/2017/055458A1
The present invention relates to trans isomers of formula (I) in the form of any one of its stereoisomers or a mixture thereof, and wherein the bold and hatched lines indicate a relative or absolute configuration; and one dotted line rep...  
WO/2017/059040A1
Disclosed are processes for the preparation of Apremilast and intermediates for its preparation.  
WO/2017/059010A1
Methods for converting an alcohol, such as cyclohexanol to a ketone, such as cyclohexanone, include reacting the alcohol in the presence of a catalyst and oxygen to produce the ketone. In one exemplary embodiment, the catalyst comprises ...  
WO/2017/051856A1
A method for producing a specific enantiomer in a larger amount than the other enantiomer, said method comprising reacting a reaction substrate in the presence of cellulose nanofiber or a derivative thereof and a catalyst so as to improv...  
WO/2017/052790A1
Aromatic compositions useful in various applications, such as aromatic fluid solvents and high temperature heat transfer fluids, are provided herein. Also provided are advantageous methods for obtaining the aromatic compositions, utilizi...  
WO/2017/045931A1
The present invention relates to compounds according to formula (I) and to heat-curable resin compositions based on polymaleimide resin systems comprising such compounds as co-monomers:, (I) wherein Dis an x-functional group; and x is an...  
WO/2017/042683A1
Aspects of the present invention relates to an isolated intermediate of Dapagliflozin (Formula III) and its preparation, process for the preparation of Dapagliflozin, process for the preparation of crystalline propane-1,2,3-triol solvate...  
WO/2017/042088A1
The present invention relates to a process for producing cumene and/or sec- butylbenzene comprising contacting benzene with a mixed olefins stream comprising ethylene and an alkylation agent in the presence of a selective alkylation cata...  
WO/2017/041036A1
Radiation therapy or chemotherapy may cause oral mucositis. Compositions are disclosed here which prevent and/or treat oral mucositis caused by radiation therapy or chemotherapy. The compositions are also effective in treating a number o...  
WO/2017/035099A1
The present specification discloses pest control compositions, articles of manufacture, containers or kits comprising such compositions, and methods and uses to control a population of invertebrate pests from a mammal, location, plant, s...  
WO/2017/029313A1
The present invention relates to a process for preparing 1-(2,6,6-trimethylcyclohex-2- en-1-yl)but-2-en-1-one, which comprises a) providing 6,10-dimethylundeca-1,5,9-trien-4-ol, b) oxidizing 6,10-dimethylundeca-1,5,9-trien-4-ol provided ...  
WO/2017/020125A1
The present application is directed to transdermal formulations comprising one or more capsaicinoinds, one or more 1,4-dialdehyde sesquiterpenes, a penetration enhancer comprising tetrahydropiperine and a transdermal formulation base. Th...  
WO/2017/023430A1
Disclosed are novel processes for making cyclohexanone compositions, from a mixture comprising phenol, cyclohexanone, and cyclohexylbenzene. The process includes hydrogenation of a feed stream comprising phenol, cyclohexanone, and cycloh...  
WO/2017/023429A1
Disclosed are novel processes for making cyclohexanone compositions, from a mixture comprising phenol, cyclohexanone, and cyclohexylbenzene. The process includes hydrogenation of a feed stream comprising phenol, cyclohexanone, and cycloh...  
WO/2017/011917A1
Methods for treating polycystic kidney disease (PKD) in a subject comprising administering a 5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK) modulator or activator. Also kits comprising AMPK modulator or activators and i...  
WO/2017/013865A1
The invention addresses the problem of providing a method for producing 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione that is suited to industrial production. The invention provides a method for producing 2-acetyl-4H,9H-naphtho[2,3-b]fura...  
WO/2017/012478A1
Disclosed are a functionalized cyanosilane and a synthesis method thereof, wherein the method comprises adding the raw material silane and the cyanogen source MCN to an organic solvent, and synthesizing the functionalized cyanosilane und...  
WO/2017/009860A1
The anticancer activity of gallic acid compounds has been invented, in order to obtain new potent and cost effective molecule using in vitro cytotoxicity assay. The invention particularly relates to the gallic acid based new molecules i....  
WO/2017/002120A1
Compounds useful for selectively eliminating senescent cells, compositions comprising same and uses thereof in treating diseases and disorders in which selective elimination of senescent cells is beneficial are provided. The compounds ar...  
WO/2017/003209A1
The present application relates to a distillation apparatus. According to the distillation apparatus of the present application, since a second compound, which has a relatively high boiling point between first and second compounds capabl...  

Matches 651 - 700 out of 14,157